Eribulin mesylate exerts antitumor effects via CD103

Eribulin mesylate (ERB) is a synthetic analog of halichondrin B, inhibiting tumor cell growth by disrupting microtubule function. Recently, anticancer drugs have been shown to not only act directly on tumor cells but also to exert antitumor effects by modifying the tumor environment. Although ERB ha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kazumasa Oya, Yoshiyuki Nakamura, Rei Watanabe, Ryota Tanaka, Yuki Ichimura, Noriko Kubota, Yutaka Matsumura, Hideaki Tahara, Naoko Okiyama, Manabu Fujimoto, Toshifumi Nomura, Yasuhiro Fujisawa
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis Group 2023-12-01
Colecção:OncoImmunology
Assuntos:
antitumor effect
CD103
eribulin mesylate
immune checkpoint
resident memory T cells
Acesso em linha:https://www.tandfonline.com/doi/10.1080/2162402X.2023.2218782
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados